1U95 | Immune System | date | Aug 09, 2004 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of The Hiv-1 Cross Neutralizing Monoclonal Antibody 2f5 In Complex With Gp41 Peptide Eldhwas | ||||||||||||||
authors | S.Bryson, J.P.Julien, R.C.Hynes, E.F.Pai | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Antibody 2f5 (Light Chain) Chain: A |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 | ||||||||||||||
Molecule: Antibody 2f5 (Heavy Chain) Chain: B |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 | ||||||||||||||
Molecule: Gp41 Peptide Chain: C Engineered: Yes |
Synthetic: Yes Organism_scientific: Human Immunodeficiency Virus 1 Organism_taxid: 11676 Other_details: Synthetic Peptide | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.24 Å | ||||||||||||
related structures | by homologous chain: 1G9M, 1NL0, 1U8K | ||||||||||||||
Primary reference | Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications., Bryson S, Julien JP, Hynes RC, Pai EF, J Virol. 2009 Nov;83(22):11862-75. Epub 2009 Sep 9. PMID:19740978 |
Data retrieval |
View 1U95 in 3D |
Visual 3D analysis of 1U95 |
Structure-derived information |
- Domain d1u95a1, region A:1-107 [Jmol] [rasmolscript] [script source] - Domain d1u95a2, region A:107-214 [Jmol] [rasmolscript] [script source] - Domain d1u95b1, region B:1-113 [Jmol] [rasmolscript] [script source] - Domain d1u95b2, region B:114-216 [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1U95 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |